On the Seeding and Oligomerization of pGlu-Amyloid Peptides (in vitro)

Schilling, Stephan, Lauber, Thomas, Schaupp, Michael, Manhart, Susanne, Scheel, Eike, Böhm, Gerald, Demuth, Hans-Ulrich·2006·Biochemistry

DOI 10.1021/bi0612667

Cited by (258)

Items 101–200 of 258

Human glutaminyl cyclase: Structure, function, inhibitors and involvement in Alzheimer’s disease
Kalarickal Vijayan Dileep, Kam Y. J. Zhang · 2019 · Pharmacological Research
Rationale and study design of a randomized, placebo-controlled, double-blind phase 2b trial to evaluate efficacy, safety, and tolerability of an oral glutaminyl cyclase inhibitor varoglutamstat (PQ912) in study participants with MCI and mild AD—VIVIAD
Everard G.B. Vijverberg, Thomas Axelsen, Asger Reinstrup Bihlet, Kim Henriksen, F. Weber, Katharina Fuchs, John Harrison, Kerstin Kühn‐Wache, Peter Alexandersen, Niels D. Prins et al. · 2021 · Alzheimer s Research & Therapy
Alzheimer's Aβ Peptides with Disease-Associated N-Terminal Modifications: Influence of Isomerisation, Truncation and Mutation on Cu2+ Coordination
Simon C. Drew, Colin Louis Masters, Kevin Jeffrey Barnham · 2010 · PLoS ONE
Rapid amyloid‐β oligomer and protofibril accumulation in traumatic brain injury
Sami Abu Hamdeh, Erik Rollman Waara, Christer Möller, Linda Söderberg, Hans Basun, Irina I. Alafuzoff, Lars Hillered, Lars Lannfelt, Martin Ingelsson, Niklas Marklund · 2017 · Brain Pathology
Transcriptional and post‐transcriptional regulation of β‐secretase
Tamagno, Elena, Guglielmotto, M., Monteleone, D., Vercelli, A., Tabaton, M. · 2012 · IUBMB Life
Alzheimer’s Disease Biomarkers Revisited From the Amyloid Cascade Hypothesis Standpoint
Deborah O T Alawode, Nick C. Fox, Henrik Zetterberg, Amanda Heslegrave · 2022 · Frontiers in Neuroscience
Glutaminyl Cyclase Knock-out Mice Exhibit Slight Hypothyroidism but No Hypogonadism
Stephan Schilling, Stephanie Kohlmann, Christoph Bäuscher, Reinhard Sedlmeier, Birgit Maria Koch, Rico Eichentopf, Andreas Becker, Holger Cynis, Torsten Hoffmann, Sabine Berg et al. · 2011 · Journal of Biological Chemistry
Distinct glutaminyl cyclase expression in Edinger–Westphal nucleus, locus coeruleus and nucleus basalis Meynert contributes to pGlu-Aβ pathology in Alzheimer’s disease
Markus Morawski, Maike Hartlage‐Rübsamen, Carsten Jäger, Alexander Waniek, Stephan Schilling, Claudia Schwab, Patrick L. McGeer, Thomas Arendt, Hans‐Ulrich Demuth, Steffen Roßner · 2010 · Acta Neuropathologica
A conserved hydrogen-bond network in the catalytic centre of animal glutaminyl cyclases is critical for catalysis
Kai-Fa Huang, Yu-Ruei Wang, En-Cheng Chang, Tsung-Lin Chou, Andrew H.‐J. Wang · 2008 · Biochemical Journal
Glutaminyl Cyclase, Diseases, and Development of Glutaminyl Cyclase Inhibitors
Chenshu Xu, Yinan Wang, Haiqiang Wu · 2021 · Journal of Medicinal Chemistry
Systematic Aβ Analysis in Drosophila Reveals High Toxicity for the 1-42, 3-42 and 11-42 Peptides, and Emphasizes N- and C-Terminal Residues
Maria Jonson, Małgorzata Pokrzywa, Annika Starkenberg, Per Hammarström, Stefan Thor · 2015 · PLoS ONE
Discovery of Conformationally Restricted Human Glutaminyl Cyclase Inhibitors as Potent Anti-Alzheimer’s Agents by Structure-Based Design
Van-Hai Hoang, Van T.H. Ngo, Minghua Cui, Nguyễn Văn Mạnh, Phuong‐Thao Tran, Jihyae Ann, Hee-Jin Ha, Hee Kim, Kwang‐Hyun Choi, Young-Ho Kim et al. · 2019 · Journal of Medicinal Chemistry
Developmental expression and subcellular localization of glutaminyl cyclase in mouse brain
Maike Hartlage‐Rübsamen, Katharina Staffa, Alexander Waniek, Michael Wermann, Torsten Hoffmann, Holger Cynis, Stephan Schilling, Hans‐Ulrich Demuth, Steffen Roßner · 2009 · International Journal of Developmental Neuroscience
Amyloid Imaging in Alzheimer’s Disease and Other Dementias
Michelle T. Fodero‐Tavoletti, Roberto Cappai, Catriona McLean, Kerryn Elizabeth Pike, Paul Anthony Adlard, Tiffany Cowie, Andrea R. Connor, Colin Louis Masters, Christopher Cleon Rowe, Victor L. Villemagne · 2009 · Brain Imaging and Behavior
Disturbed Ca2+ Homeostasis Increases Glutaminyl Cyclase Expression; Connecting Two Early Pathogenic Events in Alzheimer’s Disease In Vitro
Line De Kimpe, Anna Bennis, Rob Zwart, Elise S. van Haastert, Jeroen J.M. Hoozemans, Wiep Scheper · 2012 · PLoS ONE
Molecular imaging of dementia
Takaaki Mori, Jun Maeda, Hitoshi Shimada, Makoto Higuchi, Hitoshi Shinotoh, Shuichi Ueno, Tetsuya Suhara · 2012 · Psychogeriatrics
Structural Analysis and Aggregation Propensity of Pyroglutamate Aβ(3-40) in Aqueous Trifluoroethanol
Christina Dammers, Lothar Gremer, Kerstin Reiß, Antonia Nicole Klein, Philipp Neudecker, Rudolf Hartmann, Na Sun, Hans‐Ulrich Demuth, Melanie Schwarten, Dieter Willbold · 2015 · PLoS ONE
Linked Production of Pyroglutamate-Modified Proteins via Self-Cleavage of Fusion Tags with TEV Protease and Autonomous N-Terminal Cyclization with Glutaminyl Cyclase In Vivo
Yan‐Ping Shih, Chi‐Chi Chou, Yi‐Ling Chen, Kai-Fa Huang, Andrew H.‐J. Wang · 2014 · PLoS ONE
Cortical pyroglutamate amyloid-β levels and cognitive decline in Alzheimer's disease
Violetta N. Pivtoraiko, Eric E. Abrahamson, Sue E. Leurgans, Steven Trent DeKosky, Elliott Jay Mufson, Miloš D. Ikonomović · 2014 · Neurobiology of Aging
Ensembles of protein termini and specific proteolytic signatures as candidate biomarkers of disease
Pitter F. Huesgen, Philipp F. Lange, Christopher M. Overall · 2014 · PROTEOMICS - CLINICAL APPLICATIONS
Isoaspartate containing amyloid precursor protein derived peptides alter efficacy and specificity of potential β-secretases
Livia Böhme, Torsten Hoffmann, Susanne Manhart, Raik Wolf, Hans‐Ulrich Demuth · 2008 · Biological Chemistry
Investigation of the noncovalent interactions between anti-amyloid agents and amyloid β peptides by ESI-MS
Eric Martineau, Janna M. de Guzman, Lioudmila Rodionova, Xianqi Kong, P. Mayer, Ahmed M. Aman · 2010 · Journal of the American Society for Mass Spectrometry
Neurofibrillary Tangles and the Deposition of a Beta Amyloid Peptide with a Novel N-Terminal Epitope in the Brains of Wild Tsushima Leopard Cats
James Kenn CHAMBERS, Kazuyuki Uchida, Tomoyuki Harada, Masaya Tsuboi, Masumi Sato, Masahito Kubo, Hiroaki Kawaguchi, Noriaki Miyoshi, Hajime Tsujimoto, Hiroyuki Nakayama · 2012 · PLoS ONE
The NMDA receptor antagonist Radiprodil reverses the synaptotoxic effects of different amyloid-beta (Aβ) species on long-term potentiation (LTP)
Gerhard Rammes, Franziska Seeser, Korinna Mattusch, Kaichuan Zhu, Laura T. Haas, Markus P. Kummer, Michael Thomas Heneka, Jochen Wolfgang Herms, Chris G. Parsons · 2018 · Neuropharmacology
A quantitative analysis of spontaneous isoaspartate formation from N-terminal asparaginyl and aspartyl residues
Bert H.-O. Güttler, Holger Cynis, Franziska Seifert, Hans‐Henning Ludwig, Andrea Porzel, Stephan Schilling · 2013 · Amino Acids
Citrullination of Amyloid-β Peptides in Alzheimer’s Disease
Soumya Mukherjee, Keyla A. Perez, Céline Dubois, Rebecca M. Nisbet, Qiao‐Xin Li, Shiji Varghese, Liang Jin, Ian E. Birchall, Victor A. Streltsov, Laura J. Vella et al. · 2021 · ACS Chemical Neuroscience
Mouse models of Alzheimer's disease for preclinical research
Naoto Watamura, Kaori Sato, Takaomi C. Saido · 2022 · Neurochemistry International
Reduced levels of IgM autoantibodies against N-truncated pyroglutamate Aβ in plasma of patients with Alzheimer's disease
Andrea Marcello, Oliver Wirths, Thomas Schneider-Axmann, Malin Degerman-Gunnarsson, Lars Lannfelt, Thomas A. Bayer · 2009 · Neurobiology of Aging
Development of the clinical candidate PBD-C06, a humanized pGlu3-Aβ-specific antibody against Alzheimer’s disease with reduced complement activation
Thore Hettmann, Stephen D. Gillies, Martin Kleinschmidt, Anke Piechotta, Koki Makioka, Cynthia Ann Lemere, Stephan Schilling, Jens‐Ulrich Rahfeld, Inge Lues · 2020 · Scientific Reports
β-sheet propensity controls the kinetic pathways and morphologies of seeded peptide aggregation
Alex Morriss-Andrews, Giovanni Bellesia, Joan‐Emma Shea · 2012 · The Journal of Chemical Physics
Preclinical to phase II amyloid beta (Aβ) peptide modulators under investigation for Alzheimer’s disease
Chris G. Parsons, Gerhard Rammes · 2017 · Expert Opinion on Investigational Drugs
11C-PiB PET can underestimate brain amyloid-β burden when cotton wool plaques are numerous
Eric E. Abrahamson, Julia Kofler, Carl R Becker, Julie C. Price, Kathy L. Newell, Bernardino Francesco Ghetti, Jill R. Murrell, Catriona McLean, Oscar L. López, Chester A. Mathis et al. · 2021 · Brain
Structural and functional analyses of pyroglutamate-amyloid-β-specific antibodies as a basis for Alzheimer immunotherapy
Anke Piechotta, C. Parthier, Martin Kleinschmidt, Kathrin Gnoth, Thierry Pillot, Inge Lues, Hans‐Ulrich Demuth, Stephan Schilling, Jens‐Ulrich Rahfeld, Milton T. Stubbs · 2017 · Journal of Biological Chemistry
Is the p3 Peptide (Aβ17-40, Aβ17-42) Relevant to the Pathology of Alzheimer’s Disease?1
Ariel J. Kuhn, Jevgenij A. Raskatov · 2020 · Journal of Alzheimer s Disease
Inhibitory effect of flavonoids on human glutaminyl cyclase
Manman Li, Yao Dong, Xi Yu, Yongdong Zou, Yizhi Zheng, Xianzhang Bu, Junmin Quan, Zhendan He, Haiqiang Wu · 2016 · Bioorganic & Medicinal Chemistry
Peripheral administration of nanomicelle-encapsulated anti-Aβ oligomer fragment antibody reduces various toxic Aβ species in the brain
Akiko Amano, Nobuo Sanjo, Wataru Araki, Yasutaka Anraku, Makoto Nakakido, Etsuro Matsubara, Takami Tomiyama, Tetsuya Nagata, Kouhei Tsumoto, Kazunori Kataoka et al. · 2023 · Journal of Nanobiotechnology
Multicomponent, fragment-based synthesis of polyphenol-containing peptidomimetics and their inhibiting activity on beta-amyloid oligomerization
Chiara Lambruschini, Denise Galante, Lisa Moni, Francesco Ferraro, Giulio Gancia, Renata Riva, A. Traverso, Luca Banfi, Cristina D’Arrigo · 2017 · Organic & Biomolecular Chemistry
Abundance of Aβ5-xlike immunoreactivity in transgenic 5XFAD, APP/PS1KI and 3xTG mice, sporadic and familial Alzheimer’s disease
Erika Avendaño Guzmán, Yvonne Bouter, Bernhard Clemens Richard, Lars Lannfelt, Martin Ingelsson, Anders E. Paetau, Auli Verkkoniemi‐Ahola, Oliver Wirths, Thomas A. Bayer · 2014 · Molecular Neurodegeneration
Aβ vaccination in combination with behavioral enrichment in aged beagles: effects on cognition, Aβ, and microhemorrhages
Paulina R. Davis, Ginevra Giannini, Karin Rudolph, Nathaniel T. Calloway, Christopher M. Royer, Tina L. Beckett, M. Paul Murphy, Frederick Bresch, Dieter Pagani, Thomas L Platt et al. · 2016 · Neurobiology of Aging
Immunodominant epitope and properties of pyroglutamate-modified Aβ-specific antibodies produced in rabbits
G. Acero, Karen Manoutcharian, Vitaly Vasilevko, María Elena Munguía, Tzipe Govezensky, G. Coronas, Agustín Luz-Madrigal, David H. Cribbs, Goar Gevorkian · 2009 · Journal of Neuroimmunology
Glutaminyl cyclases, the potential targets of cancer and neurodegenerative diseases
Yidan Zhang, Yifan Wang, Zhan Zhao, Weixun Peng, Peng Wang, Ximing Xu, Chenyang Zhao · 2022 · European Journal of Pharmacology
Brain Region-Specific Differences in Amyloid-β Plaque Composition in 5XFAD Mice
Angelika Sabine Bader, Marius-Uwe Gnädig, Merle Fricke, Luca Büschgens, Lena Josefine Berger, Hans‐Wolfgang Klafki, Thomas Meyer, Olaf Jahn, Sascha Weggen, Oliver Wirths · 2023 · Life
Pyroglutamylated Amyloid-β Peptide Reverses Cross β-Sheets by a Prion-Like Mechanism
Jason O. Matos, Greg Goldblatt, Jaekyun Jeon, Bo Chen, Suren A. Tatulian · 2014 · The Journal of Physical Chemistry B
Pyroglutamate-Modified Amyloid-β(3–42) Shows α-Helical Intermediates before Amyloid Formation
Christina Dammers, Kerstin Reiß, Lothar Gremer, Justin Lecher, Tamar Ziehm, Matthias Stoldt, Melanie Schwarten, Dieter Willbold · 2017 · Biophysical Journal
Cathepsin B Deficiency Improves Memory Deficits and Reduces Amyloid-β in hAβPP Mouse Models Representing the Major Sporadic Alzheimer’s Disease Condition
Gregory Hook, Mark S. Kindy, VIVIAN Y. H. HOOK · 2023 · Journal of Alzheimer s Disease
A New Amyloid-Like β-Aggregate with Amyloid Characteristics, Except Fibril Morphology
Evan S.‐H. Chang, Tai‐Yan Liao, Tsong‐Shin Lim, Wunshain S. Fann, Rita P.‐Y. Chen · 2008 · Journal of Molecular Biology
Concerted action of dipeptidyl peptidase IV and glutaminyl cyclase results in formation of pyroglutamate-modified amyloid peptides in vitro
Alvard A. Antonyan, Dagmar Schlenzig, Stephan Schilling, Marcel Naumann, Svetlana G. Sharoyan, Sona S. Mardanyan, Hans‐Ulrich Demuth · 2017 · Neurochemistry International
From Alpha to Omega with Aβ: Targeting the Multiple Molecular Appearances of the Pathogenic Peptide in Alzheimers Disease
Line De Kimpe, Wiep Scheper · 2009 · Current Medicinal Chemistry
Role of Biochemical Alzheimer's Disease Biomarkers as End Points in Clinical Trials
Eric Siemers, Ronald Bradley Demattos, Patrick C. May, Robert A. Dean · 2010 · Biomarkers in Medicine
Structural analysis of the pyroglutamate‐modified isoform of the Alzheimer's disease‐related amyloid‐β using NMR spectroscopy
Na Sun, Rudolf Hartmann, Justin Lecher, Matthias Stoldt, Susanne Aileen Funke, Lothar Gremer, Hans‐Henning Ludwig, Hans‐Ulrich Demuth, Martin Kleinschmidt, Dieter Willbold · 2012 · Journal of Peptide Science
Purification and Characterization of Recombinant N-Terminally Pyroglutamate-Modified Amyloid-β Variants and Structural Analysis by Solution NMR Spectroscopy
Christina Dammers, Lothar Gremer, Philipp Neudecker, Hans‐Ulrich Demuth, Melanie Schwarten, Dieter Willbold · 2015 · PLoS ONE
Study on Aβ34 biology and detection in transgenic mice brains.
C. Caillava, S. Ranaldi, Inger Lauritzen, Charlotte Bauer, J. Fareh, Jean-Daniel Abraham, F. Checler · 2014 · Neurobiology of Aging
Oligomeric Pyroglutamate Amyloid-β is Present in Microglia and a Subfraction of Vessels in Patients with Alzheimer's Disease: Implications for Immunotherapy
Oliver Wirths, Antje Hillmann, Laurent Pradier, Wolfgang Härtig, Thomas A. Bayer · 2013 · Journal of Alzheimer s Disease
Abundant pyroglutamate-modified ABri and ADan peptides in extracellular and vascular amyloid deposits in familial British and Danish dementias
Anika Saul, Tammaryn Lashley, Tamás Révész, Janice L. Holton, Jorge A. Ghiso, Janaky Coomaraswamy, Oliver Wirths · 2012 · Neurobiology of Aging
Familial Presenilin Mutations and Sporadic Alzheimer’s Disease Pathology: Is the Assumption of Biochemical Equivalence Justified?
Alex E. Roher, Chera L. Maarouf, Tyler A. Kokjohn · 2016 · Journal of Alzheimer s Disease
Amyloid-beta peptide Aβp3-42 affects early aggregation of full-length Aβ1-42
Hiromi M. Sanders, Robert M. Lust, Jan K. Teller · 2009 · Peptides
Unmodified and pyroglutamylated amyloid β peptides form hypertoxic hetero‐oligomers of unique secondary structure
Greg Goldblatt, Lucia Cilenti, Jason O. Matos, Briana Lee, Nicholas Ciaffone, Qing X. Wang, Laurène Tétard, Ken Teter, Suren A. Tatulian · 2017 · FEBS Journal
Isotope-edited FTIR reveals distinct aggregation and structural behaviors of unmodified and pyroglutamylated amyloid β peptides
Greg Goldblatt, Jason O. Matos, Jeremy Gornto, Suren A. Tatulian · 2015 · Physical Chemistry Chemical Physics
Functions of glutaminyl cyclase and its isoform in diseases
Yue Liu, Yufeng Shi, Ping Wang · 2023 · Visualized Cancer Medicine
RETRACTED: Detection of Peri-Synaptic Amyloid-β Pyroglutamate Aggregates in Early Stages of Alzheimer's Disease and in AβPP Transgenic Mice Using a Novel Monoclonal Antibody
Markus Mandler, Edward M. Rockenstein, Kiren K. Ubhi, Lawrence A. Hansen, Anthony Adame, Sarah A. Michael, Douglas R Galasko, Radmila Santic, Frank Mattner, Eliezer Masliah · 2012 · Journal of Alzheimer s Disease · Retracted
In-vivo visualization of key molecular processes involved in Alzheimer's disease pathogenesis: Insights from neuroimaging research in humans and rodent models
Makoto Higuchi, Jun Maeda, Bin Ji, Masahiro Maruyama, Takashi Okauchi, Masaki Tokunaga, Maiko Ono, Tetsuya Suhara · 2010 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
Correlation of pyroglutamate amyloid β and ptau Ser202/Thr205 levels in Alzheimer’s disease and related murine models
Joerg Neddens, Magdalena Daurer, Stefanie Flunkert, Kerstin Beutl, Tina Loeffler, Lauren Walker, Johannes Attems, Birgit Hutter‐Paier · 2020 · PLoS ONE
Mouse strain and brain region‐specific expression of the glutaminyl cyclases QC and isoQC
Corinna Höfling, Henrike Indrischek, Theodor Höpcke, Alexander Waniek, Holger Cynis, Birgit Maria Koch, Stephan Schilling, Markus Morawski, Hans‐Ulrich Demuth, Steffen Roßner et al. · 2014 · International Journal of Developmental Neuroscience
Relevance of plasma biomarkers to pathologies in Alzheimer’s disease, Parkinson’s disease and frontotemporal dementia
Pai‐Yi Chiu, Fu‐Chi Yang, Ming‐Jang Chiu, Wei-Che Lin, Cheng‐Hsien Lu, Shieh‐Yueh Yang · 2022 · Scientific Reports
N-truncation and pyroglutaminylation enhances the opsonizing capacity of Aβ-peptides and facilitates phagocytosis by macrophages and microglia
Mateja Condic, Timo Jan Oberstein, Martin Herrmann i, Mareike Carola Reimann, Johannes Kornhuber, Juan Manuel Maler, Philipp Spitzer · 2014 · Brain Behavior and Immunity
Aβ1-17 is a Major Amyloid-β Fragment Isoform in Cerebrospinal Fluid and Blood with Possible Diagnostic Value in Alzheimer's Disease
Virginia Pérez‐Grijalba, Pedro Pesini, José Antonio Allué, Leticia Sarasa, María Montañés, Ana-María Lacosta, Diego Casabona, Itziar San José, Merçé Boada, Lluís Tárraga et al. · 2014 · Journal of Alzheimer s Disease
Synergistic Effect on Neurodegeneration by N-Truncated Aβ4−42 and Pyroglutamate Aβ3−42 in a Mouse Model of Alzheimer's Disease
José Sócrates López‐Noguerola, Nicolai Maurice-Etienne Gießen, Maximilian Ueberück, Julius Nicolai Meißner, Charlotte E. Pelgrim, Johnathan Adams, Oliver Wirths, Yvonne Bouter, Thomas A. Bayer · 2018 · Frontiers in Aging Neuroscience
Effects of Prion Protein on Aβ42 and Pyroglutamate-Modified AβpΕ3-42 Oligomerization and Toxicity
Katiuscia Pagano, Denise Galante, Cristina D’Arrigo, Alessandro Corsaro, Mario Nizzari, Tullio Florio, Henriette Molinari, Simona Tomaselli, Laura Ragona · 2018 · Molecular Neurobiology
Glutaminyl cyclase inhibitor exhibits anti-inflammatory effects in both AD and LPS-induced inflammatory model mice
Xiaojuan Wang, Li Wang, Xi Yu, Yue Li, Zhigang Liu, Yongdong Zou, Yizhi Zheng, Zhendan He, Haiqiang Wu · 2019 · International Immunopharmacology
Antibody 9D5 Recognizes Oligomeric Pyroglutamate Amyloid-β in a Fraction of Amyloid-β Deposits in Alzheimer's Disease without Cross-Reactivity with other Protein Aggregates
Vivek Venkataramani, Oliver Wirths, Herbert Budka, Wolfgang Härtig, Gábor Géza Kovács, Thomas A. Bayer · 2012 · Journal of Alzheimer s Disease
Donanemab removes Alzheimer's plaques: what is special about its target?
Deborah O T Alawode, Amanda Heslegrave, Nick C. Fox, Henrik Zetterberg · 2021 · The Lancet Healthy Longevity
Discovery of highly potent human glutaminyl cyclase (QC) inhibitors as anti-Alzheimer's agents by the combination of pharmacophore-based and structure-based design
Nguyễn Văn Mạnh, Van-Hai Hoang, Van T.H. Ngo, Jihyae Ann, Taeho Jang, Jung-Hye Ha, Jae Young Song, Hee-Jin Ha, Hee Kim, Young-Ho Kim et al. · 2021 · European Journal of Medicinal Chemistry
β-Amyloid-aluminum complex alters cytoskeletal stability and increases ROS production in cortical neurons
Silvia Bolognin, Paolo F. Zatta, Erika Lorenzetto, Maria Teresa Valenti, Mario Buffelli · 2013 · Neurochemistry International
Fibrils of Truncated Pyroglutamyl-Modified Aβ Peptide Exhibit a Similar Structure as Wildtype Mature Aβ Fibrils
Holger A. Scheidt, Juliane Adler, Martin C. Krueger, Daniel Huster · 2016 · Scientific Reports
Neuron Loss and Behavioral Deficits in the TBA42 Mouse Model Expressing N-Truncated Pyroglutamate Amyloid-β3–42
Meißner, Julius N., Bouter, Yvonne, Bayer, Thomas A. · 2015 · Journal of Alzheimer s Disease
The structure of tyrosine-10 favors ionic conductance of Alzheimer’s disease-associated full-length amyloid-β channels
Abhijith G. Karkisaval, Rowan Hassan, Andrew Nguyen, Benjamin Balster, Faisal Abedin, Ratnesh Lal, Suren A. Tatulian · 2024 · Nature Communications
Probing Secondary Glutaminyl Cyclase (QC) Inhibitor Interactions Applying an in silico‐Modeling/Site‐Directed Mutagenesis Approach: Implications for Drug Development
Birgit Maria Koch, Mirko Buchholz, Michael Wermann, Ulrich F. Heiser, Stephan Schilling, Hans‐Ulrich Demuth · 2012 · Chemical Biology & Drug Design
Deceleration of the neurodegenerative phenotype in pyroglutamate-Aβ accumulating transgenic mice by oral treatment with the Aβ oligomer eliminating compound RD2
Sarah Schemmert, Elena Schartmann, Dominik Honold, Christian Zafiu, Tamar Ziehm, Karl‐Josef Langen, Nadim Jon Shah, Janine Kutzsche, Antje Willuweit, Dieter Willbold · 2018 · Neurobiology of Disease
Synthesis and evaluation of [ 11 C]PBD150, a radiolabeled glutaminyl cyclase inhibitor for the potential detection of Alzheimer's disease prior to amyloid β aggregation
Allen Frederick Brooks, Isaac M. Jackson, Xia Shao, George Kropog, Phillip S. Sherman, Carole Quesada, Peter J. H. Scott · 2015 · MedChemComm
Structures of Aβ-Related Peptide−Monoclonal Antibody Complexes,
Anna S. Gardberg, Lezlee T. Dice, Kathleen Pridgen, Jan Ko, Paul H. Patterson, Susan Ker-hwa Ou, Ronald B. Wetzel, Chris Godfrey Dealwis · 2009 · Biochemistry
Pyroglutamyl-N-terminal prion protein fragments in sheep brain following the development of transmissible spongiform encephalopathies
Adriana Gielbert, Jake W Thorne, James Hope · 2015 · Frontiers in Molecular Biosciences
N-Terminal Modified Aβ Variants Enable Modulations to the Structures and Cytotoxicity Levels of Wild-Type Aβ Fibrils through Cross-Seeding
Zhiwen Hu, Dan Fai Au, Letticia Cruceta, Liliya Vugmeyster, Wei Qiang · 2020 · ACS Chemical Neuroscience
Structural Insights into Seeding Mechanisms of hIAPP Fibril Formation
Saba Suladze, Christian Sustay Martinez, Diana C. Rodriguez Camargo, Jonas Engler, Natalia P. Rodina, Riddhiman Sarkar, Martin Zacharias, Bernd Reif · 2024 · Journal of the American Chemical Society
Identification of isoAsp7-Aβ as a major Aβ variant in Alzheimer’s disease, dementia with Lewy bodies and vascular dementia
Sarah Schrempel, Anna Katharina Kottwitz, Anke Piechotta, Kathrin Gnoth, Luca Büschgens, Maike Hartlage‐Rübsamen, Markus Morawski, Mathias Schenk, Martin Kleinschmidt, Geidy E. Serrano et al. · 2024 · Acta Neuropathologica
Crystal Structures of Glutaminyl Cyclases (QCs) fromDrosophila melanogasterReveal Active Site Conservation between Insect and Mammalian QCs
Birgit Maria Koch, Petr Kolenko, Mirko Buchholz, David Ruiz Carrillo, C. Parthier, Michael Wermann, Jens‐Ulrich Rahfeld, Günter Reuter, Stephan Schilling, Milton T. Stubbs et al. · 2012 · Biochemistry
Anti-11[E]-pyroglutamate-modified amyloid β antibodies cross-react with other pathological Aβ species: Relevance for immunotherapy
Roxanna Pérez-Garmendia, Vanessa Ibarra-Bracamontes, Vitaly Vasilevko, José Luna‐Muñoz, Raúl Mena, Tzipe Govezensky, Gonzalo Acero, Karen Manoutcharian, David H. Cribbs, Goar Gevorkian · 2010 · Journal of Neuroimmunology
Very small changes in the peptide sequence alter the redox properties of Aβ(11–16)-Cu(II) and pAβ(11–16)-Cu(II) β-amyloid complexes
Magdalena Z. Wiloch, Martin Jönsson‐Niedziółka · 2022 · Journal of Electroanalytical Chemistry
Identifying hQC Inhibitors of Alzheimer’s Disease by Effective Customized Pharmacophore-Based Virtual Screening, Molecular Dynamic Simulation, and Binding Free Energy Analysis
Weicong Lin, Xiaojie Zheng, Danqing Fang, Shengfu Zhou, Wenjuan Wu, Kang‐Cheng Zheng · 2018 · Applied Biochemistry and Biotechnology
Development and evolution of human glutaminyl cyclase inhibitors (QCIs): an alternative promising approach for disease-modifying treatment of Alzheimer's disease
Daoyuan Chen, Qingxiu Chen, Xiaofei Qin, Peipei Tong, Liping Peng, Tao Zhang, Chunli Xia · 2023 · Frontiers in Aging Neuroscience
Plasma pyroglutamate‐modified amyloid beta differentiates amyloid pathology
Pei‐Ning Wang, Kun‐Ju Lin, Huei‐Chun Liu, Ulf Andréasson, Kaj Blennow, Henrik Zetterberg, Shieh‐Yueh Yang · 2020 · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring
Anti-Amyloid-β Immunotherapy for Alzheimer’s Disease
Helen Crehan, Cynthia Ann Lemere · 2016 · Elsevier eBooks
A Modification-Specific Peptide-Based immunization Approach Using CRM197 Carrier Protein: Development of a Selective Vaccine Against Pyroglutamate Aβ Peptides
Valérie Vingtdeux, Haitian Zhao, Pallavi Chandakkar, Christopher M. Acker, Peter Davies, Philippe Marambaud · 2016 · Molecular Medicine
N-Terminally Truncated Aß Peptide Variants in Alzheimer’s Disease
Oliver Wirths, Silvia Zampar, Sascha Weggen · 2019 · Codon Publications eBooks
CP-MLR/PLS directed QSAR study on the glutaminyl cyclase inhibitory activity of imidazoles: rationales to advance the understanding of activity profile
Viney Kumar, Manish Gupta, Gagandip Singh, Yenamandra S. Prabhakar · 2012 · Journal of Enzyme Inhibition and Medicinal Chemistry
Generation and Partial Characterization of Rabbit Monoclonal Antibody to Pyroglutamate Amyloid-β 3-42 (pE 3 -Aβ)
Pankaj D Mehta, Bruce A. Patrick, Marc Barshatzky, Sangita P. Mehta, Janusz Frackowiak, Bozena Mazur‐Kolecka, Jerzy Węgiel, Thomas Wısnıewskı, David L. Miller · 2018 · Journal of Alzheimer s Disease
Pyroglutamate–amyloid-β peptide expression in Drosophila leads to caspase-dependent and endoplasmic reticulum stress–related progressive neurodegeneration
Leo Tsuda, Yasuhiro Omata, Yasutoyo Yamasaki, Ryunosuke Minami, Young‐Mi Lim · 2017 · Human Molecular Genetics
Pyroglutamate-modified amyloid β(3–42) monomer has more β-sheet content than the amyloid β(1–42) monomer
Soumav Nath, Alexander Kai Buell, Bogdan Barz · 2023 · Physical Chemistry Chemical Physics
Mutual structural effects of unmodified and pyroglutamylated amyloid β peptides during aggregation
Faisal Abedin, Suren A. Tatulian · 2021 · Journal of Peptide Science
Identification of thyrotropin-releasing hormone as hippocampal glutaminyl cyclase substrate in neurons and reactive astrocytes
Alexander Waniek, Maike Hartlage‐Rübsamen, Corinna Höfling, Astrid Kehlen, Stephan Schilling, Hans‐Ulrich Demuth, Steffen Roßner · 2014 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
The Development of Small Molecule Inhibitors of Glutaminyl Cyclase and Isoglutaminyl Cyclase for Alzheimer's Disease
Ana Xu, Feng He, Chenggong Yu, Ying Qu, Qiuqiong Zhang, Jiahui Lv, Xiangna Zhang, Yingying Ran, Chao Wei, Jingde Wu · 2019 · ChemistrySelect